JP Morgan Chase’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.4M | Sell |
326,711
-99,673
| -23% | -$538K | ﹤0.01% | 4365 |
|
|
2025
Q4 | $2.71M | Buy |
426,384
+32,218
| +8% | +$224K | ﹤0.01% | 3857 |
|
|
2025
Q3 | $3.68M | Sell |
394,166
-101,102
| -20% | -$1.02M | ﹤0.01% | 3623 |
|
|
2025
Q2 | $7.14M | Buy |
495,268
+201,972
| +69% | +$1.99M | ﹤0.01% | 2839 |
|
|
2025
Q1 | $2.02M | Sell |
293,296
-47,925
| -14% | -$301K | ﹤0.01% | 3856 |
|
|
2024
Q4 | $1.81M | Buy |
341,221
+9,305
| +3% | +$50.9K | ﹤0.01% | 4227 |
|
|
2024
Q3 | $1.21M | Buy |
331,916
+33,150
| +11% | +$104K | ﹤0.01% | 4350 |
|
|
2024
Q2 | $816K | Buy |
298,766
+249,784
| +510% | +$836K | ﹤0.01% | 4397 |
|
|
2024
Q1 | $170K | Buy |
48,982
+43,154
| +740% | +$79.8K | ﹤0.01% | 5426 |
|
|
2023
Q4 | $8.33K | Buy |
5,828
+4,847
| +494% | +$6.75K | ﹤0.01% | 6450 |
|
|
2023
Q3 | $1.43K | Buy |
981
+55
| +6% | +$86 | ﹤0.01% | 6595 |
|
|
2023
Q2 | $1.45K | Buy |
926
+692
| +296% | +$1.03K | ﹤0.01% | 6397 |
|
|
2023
Q1 | $0 | Hold |
234
| – | – | ﹤0.01% | 7330 |
|
|
2022
Q4 | $0 | Sell |
234
-9,334
| -98% | -$14.8K | ﹤0.01% | 7092 |
|
|
2022
Q3 | $11K | Buy |
9,568
+9,334
| +3,989% | +$15K | ﹤0.01% | 5947 |
|
|
2022
Q2 | $0 | Sell |
234
-51,606
| -100% | -$101K | ﹤0.01% | 6979 |
|
|
2022
Q1 | $128K | Buy |
51,840
+33,625
| +185% | +$91.9K | ﹤0.01% | 5399 |
|
|
2021
Q4 | $68K | Hold |
18,215
| – | – | ﹤0.01% | 5835 |
|
|
2021
Q3 | $115K | Buy |
18,215
+119
| +0.7% | +$981 | ﹤0.01% | 5502 |
|
|
2021
Q2 | $178K | Buy |
18,096
+2,534
| +16% | +$22.1K | ﹤0.01% | 5305 |
|
|
2021
Q1 | $145K | Sell |
15,562
-101,663
| -87% | -$806K | ﹤0.01% | 5277 |
|
|
2020
Q4 | $563K | Buy |
117,225
+82,552
| +238% | +$402K | ﹤0.01% | 4301 |
|
|
2020
Q3 | $139K | Buy |
34,673
+1,146
| +3% | +$5.53K | ﹤0.01% | 4553 |
|
|
2020
Q2 | $154K | Buy |
33,527
+20,393
| +155% | +$91.3K | ﹤0.01% | 4392 |
|
|
2020
Q1 | $43K | Buy |
13,134
+202
| +2% | +$776 | ﹤0.01% | 4773 |
|
|
2019
Q4 | $56K | Sell |
12,932
-16,106
| -55% | -$57.2K | ﹤0.01% | 5092 |
|
|
2019
Q3 | $114K | Sell |
29,038
-15,769
| -35% | -$67.2K | ﹤0.01% | 4852 |
|
|
2019
Q2 | $208K | Buy |
44,807
+35,418
| +377% | +$151K | ﹤0.01% | 4650 |
|
|
2019
Q1 | $39K | Sell |
9,389
-441
| -4% | -$1.59K | ﹤0.01% | 5215 |
|
|
2018
Q4 | $34K | Buy |
9,830
+916
| +10% | +$3.18K | ﹤0.01% | 5201 |
|
|
2018
Q3 | $38K | Buy |
8,914
+1,099
| +14% | +$4.72K | ﹤0.01% | 5286 |
|
|
2018
Q2 | $29K | Buy |
+7,815
| New | +$29.7K | ﹤0.01% | 5236 |
|
|
2018
Q1 | – | Sell |
-40,109
| Closed | -$236K | – | 5675 |
|
|
2017
Q4 | $236K | Buy |
40,109
+21,471
| +115% | +$116K | ﹤0.01% | 4359 |
|
|
2017
Q3 | $81K | Buy |
+18,638
| New | +$68.1K | ﹤0.01% | 4357 |
|
|
2017
Q2 | – | Sell |
-19,406
| Closed | -$52K | – | 5278 |
|
|
2017
Q1 | $52K | Sell |
19,406
-19,484
| -50% | -$55.3K | ﹤0.01% | 4517 |
|
|
2016
Q4 | $129K | Buy |
+38,890
| New | +$106K | ﹤0.01% | 4325 |
|
Other funds holding NAGE
SW
VCM
TCM
